Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Change in Acquisitions & Divestments: 2016-2017

Historic Change in Acquisitions & Divestments for Tvardi Therapeutics (TVRD) over the last 2 years, with Dec 2017 value amounting to $16.8 million.

  • Tvardi Therapeutics' Change in Acquisitions & Divestments fell 19.20% to $16.8 million in Q4 2017 from the same period last year, while for Dec 2017 it was $82.2 million, marking a year-over-year increase of 2.21%. This contributed to the annual value of $82.0 million for FY2024, which is 47.25% down from last year.
  • As of Q4 2017, Tvardi Therapeutics' Change in Acquisitions & Divestments stood at $16.8 million, which was down 43.22% from $29.5 million recorded in Q3 2017.
  • Tvardi Therapeutics' Change in Acquisitions & Divestments' 5-year high stood at $29.5 million during Q3 2017, with a 5-year trough of $16.2 million in Q1 2017.
  • In the last 2 years, Tvardi Therapeutics' Change in Acquisitions & Divestments had a median value of $18.5 million in 2016 and averaged $20.3 million.
  • The largest annual percentage gain for Tvardi Therapeutics' Change in Acquisitions & Divestments in the last 5 years was 71.01% (2017), contrasted with its biggest fall of 37.98% (2017).
  • Over the past 2 years, Tvardi Therapeutics' Change in Acquisitions & Divestments (Quarterly) stood at $20.7 million in 2016, then fell by 19.20% to $16.8 million in 2017.
  • Its Change in Acquisitions & Divestments stands at $16.8 million for Q4 2017, versus $29.5 million for Q3 2017 and $19.8 million for Q2 2017.